244 related articles for article (PubMed ID: 20506104)
1. Optimal nitrogen supply as a key to increased and sustained production of a monoclonal full-size antibody in BY-2 suspension culture.
Holland T; Sack M; Rademacher T; Schmale K; Altmann F; Stadlmann J; Fischer R; Hellwig S
Biotechnol Bioeng; 2010 Oct; 107(2):278-89. PubMed ID: 20506104
[TBL] [Abstract][Full Text] [Related]
2. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
[TBL] [Abstract][Full Text] [Related]
3. Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells.
Chiang GG; Sisk WP
Biotechnol Bioeng; 2005 Sep; 91(7):779-92. PubMed ID: 15986489
[TBL] [Abstract][Full Text] [Related]
4. Expression of a human anti-rabies virus monoclonal antibody in tobacco cell culture.
Girard LS; Fabis MJ; Bastin M; Courtois D; Pétiard V; Koprowski H
Biochem Biophys Res Commun; 2006 Jun; 345(2):602-7. PubMed ID: 16690026
[TBL] [Abstract][Full Text] [Related]
5. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
[TBL] [Abstract][Full Text] [Related]
6. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
[TBL] [Abstract][Full Text] [Related]
8. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting monoclonal antibody production in culture.
Reuveny S; Velez D; Macmillan JD; Miller L
Dev Biol Stand; 1987; 66():169-75. PubMed ID: 3582746
[TBL] [Abstract][Full Text] [Related]
10. Defining process design space for monoclonal antibody cell culture.
Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
[TBL] [Abstract][Full Text] [Related]
11. Bioreactor strategies for improving production yield and functionality of a recombinant human protein in transgenic tobacco cell cultures.
Huang TK; Plesha MA; Falk BW; Dandekar AM; McDonald KA
Biotechnol Bioeng; 2009 Feb; 102(2):508-20. PubMed ID: 18767186
[TBL] [Abstract][Full Text] [Related]
12. Strategies for enhancing monoclonal antibody accumulation in plant cell and organ cultures.
Sharp JM; Doran PM
Biotechnol Prog; 2001; 17(6):979-92. PubMed ID: 11735430
[TBL] [Abstract][Full Text] [Related]
13. Impact of cell culture process changes on endogenous retrovirus expression.
Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y
Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857
[TBL] [Abstract][Full Text] [Related]
14. Optimization of BY-2 cell suspension culture medium for the production of a human antibody using a combination of fractional factorial designs and the response surface method.
Vasilev N; Grömping U; Lipperts A; Raven N; Fischer R; Schillberg S
Plant Biotechnol J; 2013 Sep; 11(7):867-74. PubMed ID: 23721307
[TBL] [Abstract][Full Text] [Related]
15. Semicontinuous bioreactor production of a recombinant human therapeutic protein using a chemically inducible viral amplicon expression system in transgenic plant cell suspension cultures.
Huang TK; Plesha MA; McDonald KA
Biotechnol Bioeng; 2010 Jun; 106(3):408-21. PubMed ID: 20198659
[TBL] [Abstract][Full Text] [Related]
16. Development of scale-down techniques for investigation of recombinant Escherichia coli fermentations: acid metabolites in shake flasks and stirred bioreactors.
Dahlgren ME; Powell AL; Greasham RL; George HA
Biotechnol Prog; 1993; 9(6):580-6. PubMed ID: 7764346
[TBL] [Abstract][Full Text] [Related]
17. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
Huang EP; Marquis CP; Gray PP
Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
[TBL] [Abstract][Full Text] [Related]
18. Monoterpenoid oxindole alkaloid production by Uncaria tomentosa (Willd) D.C. cell suspension cultures in a stirred tank bioreactor.
Trejo-Tapia G; Cerda-García-Rojas CM; Rodríguez-Monroy M; Ramos-Valdivia AC
Biotechnol Prog; 2005; 21(3):786-92. PubMed ID: 15932257
[TBL] [Abstract][Full Text] [Related]
19. Recombinant antibody production by perfusion cultures of rCHO cells in a depth filter perfusion system.
Lee JC; Chang HN; Oh DJ
Biotechnol Prog; 2005; 21(1):134-9. PubMed ID: 15903250
[TBL] [Abstract][Full Text] [Related]
20. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
Seifert DB; Phillips JA
Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
